DBTX insider filings
Decibel Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-09-25. Screen DBTX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for DBTX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Decibel Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-09-25 | 4 | Trask Anna — Chief People Officer | Disposition to issuer (D): 106,864 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 52,500 (derivative) · Disposition to issuer (D): 137,302 (derivative) | EDGAR |
| 2023-09-25 | 4 | Carson William H. — Director | Disposition to issuer (D): 5,000 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) | EDGAR |
| 2023-09-25 | 4 | Lee John Jui-Jen — Chief Development Officer | Disposition to issuer (D): 147,144 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 52,500 (derivative) · Disposition to issuer (D): 232,003 (derivative) | EDGAR |
| 2023-09-25 | 4 | FINGER ALISON CECILY — Director | Disposition to issuer (D): 5,000 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) | EDGAR |
| 2023-09-25 | 4 | Nochur Sara — Director | Disposition to issuer (D): 5,000 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) | EDGAR |
| 2023-09-25 | 4 | Kapusta Matthew C — Director | Disposition to issuer (D): 10,000 · Disposition to issuer (D): 10,000 (derivative) | EDGAR |
| 2023-09-25 | 4 | Reid Laurence — See Remarks, Director | Disposition to issuer (D): 220,849 · Disposition to issuer (D): 187,500 (derivative) · Disposition to issuer (D): 72,000 (derivative) · Disposition to issuer (D): 1,072,539 (derivative) | EDGAR |
| 2023-09-25 | 4 | MCLAUGHLIN KEVIN F — Director | Disposition to issuer (D): 5,000 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) | EDGAR |
| 2023-06-14 | 4 | Nochur Sara — Director | Grant/award (A): 5,000 @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2023-06-14 | 4 | Carson William H. — Director | Grant/award (A): 5,000 @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2023-06-14 | 4 | FINGER ALISON CECILY — Director | Grant/award (A): 5,000 @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2023-06-14 | 4 | MCLAUGHLIN KEVIN F — Director | Grant/award (A): 5,000 @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2023-03-21 | 4 | Kapusta Matthew C — Director | Grant/award (A): 10,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2023-03-17 | 4 | Reid Laurence — See Remarks, Director | Grant/award (A): 195,000 @ $0 · Grant/award (A): 72,000 (derivative) @ $0 | EDGAR |
| 2023-01-30 | 4 | Trask Anna — Chief People Officer | Grant/award (A): 105,000 @ $0 · Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2023-01-30 | 4 | Lee John Jui-Jen — Chief Development Officer | Grant/award (A): 120,000 @ $0 · Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2022-10-12 | 4 | MCLAUGHLIN KEVIN F — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-06-21 | 4 | FINGER ALISON CECILY — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2022-06-21 | 4 | Carson William H. — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2022-06-21 | 4 | Nochur Sara — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2022-06-21 | 4 | Exter Neil — Director, 10% owner | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2022-06-21 | 4 | Thompson Peter A. — Director, 10% owner | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2022-02-28 | 4 | Trask Anna — See Remarks | Grant/award (A): 52,500 (derivative) @ $0 | EDGAR |
| 2022-02-28 | 4 | Lee John Jui-Jen — Chief Development Officer | Grant/award (A): 52,500 (derivative) @ $0 | EDGAR |
| 2022-02-28 | 4 | Leiderman Elisabeth — Chief Financial Officer | Grant/award (A): 52,500 (derivative) @ $0 | EDGAR |
| 2022-02-28 | 4 | Reid Laurence — See Remarks, Director | Grant/award (A): 187,500 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4 | Trask Anna — See Remarks | Sale (S): 1 @ $5.04 · Sale (S): 377 @ $5.03 | EDGAR |
| 2021-12-06 | 4 | Trask Anna — See Remarks | Sale (S): 4,913 @ $6.37 · Sale (S): 378 @ $6.34 | EDGAR |
| 2021-12-06 | 4 | Nochur Sara — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-12-06 | 4 | FINGER ALISON CECILY — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-11-04 | 4 | Trask Anna — See Remarks | Sale (S): 378 @ $8.34 | EDGAR |
| 2021-11-03 | 4 | Trask Anna — SEE REMARKS | Sale (S): 4,913 @ $8.31 | EDGAR |
| 2021-10-15 | 4 | Trask Anna — See Remarks | Sale (S): 5,364 @ $7.55 | EDGAR |
| 2021-09-17 | 4 | Reid Laurence — President and Chief Executive, Director | Purchase (P): 10,000 @ $7.64 | EDGAR |
| 2021-08-18 | 4 | Hu Cynthia W. — General Counsel | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2021-06-03 | 4 | Carson William H. — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-03-08 | 4 | Schroder Adveq Technology IX S.C.S. — 10% owner Schroder Adveq Management Luxembourg Sarl — 10% owner Schroder Adveq cPl Global 2017 - 2019 C.V. — 10% owner Schroder Adveq cPl Global Management III L.P. — 10% owner | Conversion (C): 524,328 · Conversion (C): 524,328 · Conversion (C): 6,625,001 (derivative) · Conversion (C): 6,625,001 (derivative) | EDGAR |
| 2021-02-19 | 4 | Foy Matthew — Director, 10% owner | Conversion (C): 458,487 · Conversion (C): 247,324 · Conversion (C): 327,852 · Purchase (P): 150,000 @ $18 · Conversion (C): 7,119,852 (derivative) @ $0 · Conversion (C): 3,125,000 (derivative) @ $0 · +1 more | EDGAR |
| 2021-02-19 | 4 | Exter Neil — Director, 10% owner | Conversion (C): 2,938,945 · Conversion (C): 98,929 · Conversion (C): 54,642 · Conversion (C): 45,638,882 (derivative) @ $0 · Conversion (C): 1,250,000 (derivative) @ $0 · Conversion (C): 289,603 (derivative) @ $0 | EDGAR |
| 2021-02-19 | 4 | Casdin Partners Master Fund, L.P. — 10% owner | Conversion (C): 546,421 · Purchase (P): 575,000 @ $18 · Conversion (C): 2,896,032 (derivative) @ $0 | EDGAR |
| 2021-02-19 | 4 | Thompson Peter A. — Director, 10% owner | Conversion (C): 2,732,106 · Conversion (C): 327,852 · Conversion (C): 218,568 · Purchase (P): 1,111,100 @ $18 · Purchase (P): 555,566 @ $18 · Conversion (C): 14,480,162 (derivative) @ $0 · +2 more | EDGAR |
| 2021-02-19 | 4 | GLAXOSMITHKLINE PLC — Director | Conversion (C): 458,487 · Conversion (C): 247,324 · Conversion (C): 327,852 · Purchase (P): 150,000 @ $18 · Conversion (C): 7,119,850 (derivative) · Conversion (C): 3,125,000 (derivative) · +1 more | EDGAR |
| 2021-02-19 | 4 | ORBIMED ADVISORS LLC — Director, 10% owner OrbiMed Capital GP VIII LLC — Director, 10% owner OrbiMed Genesis GP LLC — Director, 10% owner ORBIMED CAPITAL LLC — Director, 10% owner | Conversion (C): 2,732,106 · Conversion (C): 327,852 · Conversion (C): 218,568 · Purchase (P): 1,111,100 @ $18 · Purchase (P): 555,566 @ $18 · Conversion (C): 14,480,162 (derivative) @ $0 · +2 more | EDGAR |
| 2021-02-18 | 4 | Longevity Fund 2 LP — 10% owner | Conversion (C): 79,143 · Conversion (C): 79,143 (derivative) @ $0 | EDGAR |
| 2021-02-18 | 4 | REGENERON PHARMACEUTICALS, INC. — 10% owner | Conversion (C): 2,097,314 · Conversion (C): 12,500,000 (derivative) @ $0 · Conversion (C): 14,000,000 (derivative) @ $0 | EDGAR |
| 2021-02-17 | 4 | GV 2019 GP, L.L.C. — 10% owner GV 2019 GP, L.P. — 10% owner GV 2019, L.P. — 10% owner | Conversion (C): 819,631 · Conversion (C): 4,344,048 (derivative) | EDGAR |
| 2021-02-17 | 4 | GV 2017 GP, L.L.C. — 10% owner GV 2017 GP, L.P. — 10% owner GV 2017, L.P. — 10% owner | Conversion (C): 494,649 · Conversion (C): 6,250,000 (derivative) | EDGAR |
| 2021-02-17 | 4 | GV 2016 GP, L.L.C. — 10% owner GV 2016 GP, L.P. — 10% owner GV 2016, L.P. — 10% owner | Conversion (C): 321,978 · Conversion (C): 5,000,000 (derivative) | EDGAR |
| 2021-02-16 | 4 | Thompson Peter A. — Director, 10% owner | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-02-16 | 4 | POON CHRISTINE A — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Decibel Therapeutics, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-09-25 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-08-25 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-08-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-06-13 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2023-04-06 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-03-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-03-13 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2023-01-09 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-10-17 | 8-K | 8.01 — Other Events | EDGAR |
| 2022-10-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=DBTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs